Politician(s) lobbied: Jennifer Carroll MacNeill (Minister), Department of Health
Intent: Letter to the Minister for Health, welcoming the provisions of the recent Framework Agreement on the Supply and Pricing of Medicines and thanking her for the positive collaboration between the IPHA and her Department.
Methods: Letter
Politician(s) lobbied: Billy Kelleher (MEP), European Parliament
Intent: To discuss European rare disease policy and the implications of the Biotech Act for the Irish life sciences sector.
Methods: Meeting
Politician(s) lobbied: Unknown
Intent: Unknown
Methods: Unknown
Details by Method
Method not specified
Unknown
Politician(s) lobbied: Billy Kelleher (MEP), European Parliament
Intent: Secure meeting with MEP Kelleher to discuss EU General Pharma Legislation, Critical Medicines Act, and the upcoming Biotech Act
Methods: Email
Politician(s) lobbied: Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment; Peter Burke (Minister), Department of Enterprise, Trade and Employment
Intent: Provide education on Critical Medicines Act and other biopharma industry topics
Methods: Meeting
Politician(s) lobbied: Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas
Intent: Share with an Taoiseach our views on trade policy and impact on the pharmaceuticals sector
Methods: Phone call
Politician(s) lobbied: Billy Kelleher (MEP), European Parliament
Intent: Secure meeting with MEP Billy Kelleher to discuss EU legislation
Methods: Email
Politician(s) lobbied: Cynthia Ní Mhurchú (MEP), European Parliament
Intent: Share information with MEP Cynthia NÍ MHURCHÚ on EU legislation
Methods: Meeting
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Pauline Mulligan (Assistant Secretary), Department of Enterprise, Trade and Employment
Intent: To discuss with Minister Burke Amgen's current and future investments in Ireland and emerging public policy issues of interest
Methods: Meeting
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment
Intent: Meet with Minister Burke to discuss EU pharmaceutical legislation, market access to innovative medicines, and Amgen's manufacturing footprint
Methods: Meeting
